Skip to main content

Table 2 Dosimetric outcomes for 125 oART fraction of postoperative cervical cancer

From: Prospects for daily online adaptive radiotherapy for cervical cancer: Auto-contouring evaluation and dosimetric outcomes

ROIs

Dosimetric metrics

A-Adapted plan

A-Scheduled plan

S-Adapted plan

S-Scheduled plan

p1 value

p2 value

CTV-N

V100% (%)

99.20 ± 0.92

91.37 ± 8.54

99.94 ± 0.08

97.19 ± 4.57

 < 0.05

 < 0.05

CTV-V

V100% (%)

97.13 ± 2.99

94.73 ± 4.23

99.98 ± 0.04

96.85 ± 3.70

 < 0.05

 < 0.05

PTV-N

V100% (%)

91.92 ± 2.32

85.11 ± 8.39

96.75 ± 0.32

91.84 ± 4.72

 < 0.05

 < 0.05

PTV-V

V100% (%)

91.52 ± 4.36

87.95 ± 5.74

96.41 ± 0.87

90.96 ± 5.78

 < 0.05

 < 0.05

Bladder

V40Gy (%)

23.12 ± 3.53

27.65 ± 5.38

24.05 ± 2.25

29.09 ± 5.25

 < 0.05

 = 0.04

V30Gy (%)

36.98 ± 3.76

41.50 ± 4.99

37.87 ± 3.13

43.73 ± 6.10

 < 0.05

 = 0.05

V20Gy (%)

56.44 ± 4.92

62.49 ± 7.30

59.15 ± 7.02

65.46 ± 9.99

 < 0.05

 < 0.05

V10Gy (%)

91.10 ± 3.20

93.96 ± 3.23

93.07 ± 3.42

94.52 ± 3.36

 < 0.05

 < 0.05

Dmean (Gy)

0.81 ± 0.07

0.90 ± 0.10

0.84 ± 0.07

0.94 ± 0.11

 < 0.05

 < 0.05

D50% (Gy)

0.92 ± 0.05

0.98 ± 0.07

0.95 ± 0.05

1.01 ± 0.08

 < 0.05

 < 0.05

Rectum

V40Gy (%)

39.99 ± 17.09

43.03 ± 19.91

37.50 ± 9.46

38.47 ± 16.99

 = 0.58

 = 0.38

V30Gy (%)

59.72 ± 16.57

66.97 ± 20.24

57.01 ± 9.97

62.06 ± 16.47

 < 0.05

 = 0.23

V20Gy (%)

77.07 ± 12.88

82.49 ± 14.81

74.91 ± 8.13

80.48 ± 13.00

 < 0.05

 = 0.28

V10Gy (%)

92.22 ± 6.33

93.75 ± 5.51

91.70 ± 5.79

93.15 ± 5.25

 = 0.04

 = 0.76

Dmean (Gy)

1.23 ± 0.28

1.31 ± 0.28

1.19 ± 0.17

1.26 ± 0.25

 = 0.02

 = 0.39

D50% (Gy)

1.14 ± 0.18

1.20 ± 0.21

1.12 ± 0.12

1.16 ± 0.18

 = 0.01

 = 0.44

Bone Marrow

V10Gy (%)

83.14 ± 4.51

85.15 ± 4.56

82.78 ± 5.00

84.73 ± 4.28

 < 0.05

 = 0.99

D90% (Gy)

0.25 ± 0.07

0.28 ± 0.06

0.25 ± 0.07

0.27 ± 0.06

 < 0.05

 = 0.86

Dmean (Gy)

0.79 ± 0.03

0.82 ± 0.03

0.79 ± 0.03

0.81 ± 0.03

 < 0.05

 = 0.43

Femur head left

V30Gy (%)

1.47 ± 1.92

1.98 ± 2.10

0.93 ± 0.80

1.12 ± 0.96

 = 0.09

 = 0.69

D5% (Gy)

0.82 ± 0.13

0.86 ± 0.13

0.77 ± 0.06

0.80 ± 0.07

 < 0.05

 = 0.03

Dmean (Gy)

0.44 ± 0.03

0.45 ± 0.03

0.44 ± 0.02

0.44 ± 0.02

 < 0.05

 = 0.37

Femur head right

V30Gy (%)

2.03 ± 2.33

2.31 ± 2.42

1.20 ± 0.54

1.38 ± 0.88

 = 0.05

 = 0.05

D5% (Gy)

0.87 ± 0.14

0.90 ± 0.14

0.81 ± 0.04

0.83 ± 0.07

 = 0.01

 = 0.03

Dmean (Gy)

0.45 ± 0.04

0.47 ± 0.04

0.43 ± 0.02

0.45 ± 0.03

 < 0.05

 = 0.11

Bowel

V40Gy (%)

12.44 ± 2.88

12.19 ± 3.00

12.32 ± 2.85

12.33 ± 3.09

 = 0.99

 < 0.05

V30Gy (%)

25.18 ± 3.72

24.79 ± 3.97

24.58 ± 3.84

25.00 ± 3.96

 = 0.40

 < 0.05

V20Gy (%)

50.14 ± 3.89

54.43 ± 6.69

46.51 ± 4.26

52.45 ± 6.18

 < 0.05

 < 0.05

V10Gy (%)

74.86 ± 4.77

82.38 ± 6.21

70.03 ± 4.93

79.56 ± 5.36

 < 0.05

 < 0.05

D2cm3 (Gy)

1.67 ± 0.01

1.67 ± 0.01

1.69 ± 0.01

1.69 ± 0.01

 = 0.66

 < 0.05

V40Gy (cm3)

127.53 ± 48.79

125.12 ± 50.03

126.46 ± 49.01

127.04 ± 52.19

 = 0.93

 < 0.05

V47Gy (cm3)

0.82 ± 0.83

2.25 ± 2.64

6.96 ± 7.06

7.32 ± 6.28

 = 0.67

 < 0.05

  1. p1 value represents the comparison between S-Adapted plan and S-Scheduled plan; p2 value represents the comparison between A-Adapted plan and S-Adapted plan
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us